机构:[1]Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, Germany.[2]Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.[3]Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, 513 Parnassus Avenue, San Francisco, CA, USA.[4]Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.[5]Institute of Pathology, University of Greifswald, Greifswald, Germany.[6]Experimental Pathology Unit, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.[7]School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.[8]School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.[9]Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[10]Department of Thyroid and Breast Surgery, The 960Th Hospital of the PLA, Jinan, 250031, China.中国人民解放军联勤保障部队第九六〇医院[11]National Institute of Gastroenterology, IRCCS- Saverio de Bellis Research Hospital, Castellana Grotte, Italy.[12]University of Hawaii Cancer Center, Honolulu, HI, USA.[13]Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, Germany. katja.evert@ukr.de.
第一作者机构:[1]Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, Regensburg, Germany.[2]Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
推荐引用方式(GB/T 7714):
Cigliano Antonio,Zhang Shanshan,Ribback Silvia,et al.Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease[J].Journal Of Experimental & Clinical Cancer Research : CR.2023,42(1):124.doi:10.1186/s13046-023-02709-x.
APA:
Cigliano Antonio,Zhang Shanshan,Ribback Silvia,Steinmann Sara,Sini Marcella...&Evert Katja.(2023).Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.Journal Of Experimental & Clinical Cancer Research : CR,42,(1)
MLA:
Cigliano Antonio,et al."Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease".Journal Of Experimental & Clinical Cancer Research : CR 42..1(2023):124